학술논문
Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.
Document Type
Article
Author
Source
Subject
*RIVASTIGMINE
*MULTIPLE sclerosis
*COGNITIVE testing
*MEMORY
*COGNITIVE analysis
*PATIENTS
*
*
*
*
*
Language
ISSN
1352-4585
Abstract
The article discusses a study which evaluates the efficacy on safety and memory function of Cholinesterase inhibitors (ChEI) rivastigmine in multiple sclerosis (MS) patients with cognitive deficits. The study used the selective reminding test (SRT) to measure the changes in cognitive deficits from baseline of the total recall score after 16 weeks of treatment. Results show that patients receiving rivastigmine showed a non-significant increase in total recall score.